- Home
- GITS vs CHEK Comparison
GITS vs CHEK Comparison
Compare GITS & CHEK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GITS
- CHEK
- Stock Information
- Founded
- GITS 2018
- CHEK 2004
- Country
- GITS South Korea
- CHEK Israel
- Employees
- GITS N/A
- CHEK N/A
- Industry
- GITS
- CHEK Medical Electronics
- Sector
- GITS
- CHEK Health Care
- Exchange
- GITS Nasdaq
- CHEK Nasdaq
- Market Cap
- GITS 4.8M
- CHEK 4.0M
- IPO Year
- GITS N/A
- CHEK 2015
- Fundamental
- Price
- GITS $1.46
- CHEK $0.93
- Analyst Decision
- GITS
- CHEK
- Analyst Count
- GITS 0
- CHEK 0
- Target Price
- GITS N/A
- CHEK N/A
- AVG Volume (30 Days)
- GITS 54.2K
- CHEK 167.8K
- Earning Date
- GITS 07-15-2025
- CHEK 05-27-2025
- Dividend Yield
- GITS N/A
- CHEK N/A
- EPS Growth
- GITS N/A
- CHEK N/A
- EPS
- GITS N/A
- CHEK N/A
- Revenue
- GITS N/A
- CHEK N/A
- Revenue This Year
- GITS N/A
- CHEK N/A
- Revenue Next Year
- GITS N/A
- CHEK N/A
- P/E Ratio
- GITS N/A
- CHEK N/A
- Revenue Growth
- GITS N/A
- CHEK N/A
- 52 Week Low
- GITS $0.10
- CHEK $0.56
- 52 Week High
- GITS $5.06
- CHEK $3.04
- Technical
- Relative Strength Index (RSI)
- GITS N/A
- CHEK 57.45
- Support Level
- GITS N/A
- CHEK $0.79
- Resistance Level
- GITS N/A
- CHEK $1.20
- Average True Range (ATR)
- GITS 0.00
- CHEK 0.17
- MACD
- GITS 0.00
- CHEK 0.01
- Stochastic Oscillator
- GITS 0.00
- CHEK 47.13
About GITS Global Interactive Technologies Inc. Common Stock
Global Interactive Technologies Inc, formerly Hanryu Holdings Inc is the creator of the engaging social media platform, FANTOO. Through FANTOO, it provides a multi-media platform for its users to interact with other like-minded users, share their appreciation of various types of entertainment and cultures, create their content, enjoy content, and engage in commerce.
About CHEK Check-Cap Ltd.
Check-Cap Ltd is a clinical-stage medical diagnostics company engaged in the development of an ingestible imaging capsule that utilizes low-dose X-rays for the detection and imaging of colonic polyps and colorectal cancers, or CRC. The company is developing C-Scan, the first capsule-based system for preparation-free, colorectal cancer screening. Its scanning capsule will be swallowed and propelled by natural motility through the gastrointestinal tract and excreted naturally with no need for retrieval for data collection. The operations of the company are presently located in Israel, but it currently expects to market products in the United States, Europe, Israel and Japan.